Annual report pursuant to Section 13 and 15(d)

CollabRx Acquisition (Tables)

CollabRx Acquisition (Tables)

12 Months Ended

Mar. 31, 2013

CollabRx Acquisition [Abstract]

Purchase Price Allocation for Acquisition of CollabRx

The purchase price for the CollabRx acquisition was allocated as follows:

PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX

Assets acquired:
Developed Technology		$	720
Customer Relationships			433
Trade Name			346
Non Compete Agreement			151
Cash			476
AP and accrueds			-333
Deferred tax liability			-664
Goodwill			603
Total Acquired Assets, net			1,732

Purchase Price summary:		$	932
Common Stock Consideration			500
Promissory Note Assumed			300
Loan Note Payable Assumed			1,732